PortfoliosLab logoPortfoliosLab logo
HEAL vs. IDNA
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

HEAL vs. IDNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Global X HealthTech ETF (HEAL) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HEAL achieves a -11.69% return, which is significantly lower than IDNA's 17.72% return.


HEAL

1D
-1.35%
1M
3.99%
YTD
-11.69%
6M
-14.62%
1Y
-19.29%
3Y*
-8.58%
5Y*
-14.74%
10Y*

IDNA

1D
0.46%
1M
4.69%
YTD
17.72%
6M
14.99%
1Y
51.77%
3Y*
10.60%
5Y*
-8.07%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

HEAL vs. IDNA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
HEAL
Global X HealthTech ETF
-11.69%-0.62%-2.87%-12.61%-29.99%-14.21%16.89%
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
17.72%17.26%-0.72%-7.63%-42.28%-3.98%21.46%

Correlation

The correlation between HEAL and IDNA is 0.58, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.58

Correlation (3Y)
Calculated over the trailing 3-year period

0.61

Correlation (5Y)
Calculated over the trailing 5-year period

0.70

Correlation (All Time)
Calculated using the full available price history since Jul 30, 2020

0.71

The correlation between HEAL and IDNA shifts across timeframes, from 0.58 (1 year) to 0.71 (all time), reflecting how their relationship changes across market environments.

HEAL vs. IDNA - Sectors Allocation Comparison


Sectors
HEAL
IDNA

Healthcare

96.5%
99.3%

Technology

2.9%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

0.3%

Real Estate

-

-

Utilities

-

-

Healthcare

HEAL
96.5%
IDNA
99.3%

Technology

HEAL
2.9%
IDNA

-

Basic Materials

HEAL

-

IDNA

-

Communication Services

HEAL

-

IDNA

-

Consumer Cyclical

HEAL

-

IDNA

-

Consumer Defensive

HEAL

-

IDNA

-

Energy

HEAL

-

IDNA

-

Financial Services

HEAL

-

IDNA

-

Industrials

HEAL

-

IDNA
0.3%

Real Estate

HEAL

-

IDNA

-

Utilities

HEAL

-

IDNA

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HEAL vs. IDNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HEAL
HEAL Risk / Return Rank: 33
Overall Rank
HEAL Sharpe Ratio Rank: 22
Sharpe Ratio Rank
HEAL Sortino Ratio Rank: 22
Sortino Ratio Rank
HEAL Omega Ratio Rank: 33
Omega Ratio Rank
HEAL Calmar Ratio Rank: 44
Calmar Ratio Rank
HEAL Martin Ratio Rank: 33
Martin Ratio Rank

IDNA
IDNA Risk / Return Rank: 7070
Overall Rank
IDNA Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
IDNA Sortino Ratio Rank: 6666
Sortino Ratio Rank
IDNA Omega Ratio Rank: 5555
Omega Ratio Rank
IDNA Calmar Ratio Rank: 8888
Calmar Ratio Rank
IDNA Martin Ratio Rank: 7474
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HEAL vs. IDNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X HealthTech ETF (HEAL) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HEALIDNADifference
Sharpe ratioReturn per unit of total volatility

-2.95

Sortino ratioReturn per unit of downside risk

-4.09

Omega ratioGain probability vs. loss probability

0.87

1.33

-0.46

Calmar ratioReturn relative to maximum drawdown

-0.63

4.88

-5.51

Martin ratioReturn relative to average drawdown

-1.21

13.60

-14.82

HEAL vs. IDNA - Sharpe Ratio Comparison

The current HEAL Sharpe Ratio is -0.87, which is lower than the IDNA Sharpe Ratio of 2.09. The chart below compares the historical Sharpe Ratios of HEAL and IDNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HEAL vs. IDNA - Drawdown Comparison

The maximum HEAL drawdown since its inception was -65.76%, roughly equal to the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for HEAL and IDNA.


Loading charts...

Drawdown Indicators


HEALIDNADifference

Max Drawdown

Largest peak-to-trough decline

-65.76%

-68.26%

+2.50%

Max Drawdown (1Y)

Largest decline over 1 year

-30.71%

-10.66%

-20.05%

Max Drawdown (3Y)

Largest decline over 3 years

-35.78%

-29.46%

-6.32%

Max Drawdown (5Y)

Largest decline over 5 years

-60.36%

-68.26%

+7.90%

Current Drawdown

Current decline from peak

-61.88%

-41.96%

-19.92%

Average Drawdown

Average peak-to-trough decline

-43.19%

-36.28%

-6.91%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.92%

3.82%

+12.10%

Volatility

HEAL vs. IDNA - Volatility Comparison

Global X HealthTech ETF (HEAL) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) have volatilities of 7.15% and 7.25%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HEALIDNADifference

Volatility (1M)

Calculated over the trailing 1-month period

7.15%

7.25%

-0.10%

Volatility (6M)

Calculated over the trailing 6-month period

16.56%

18.40%

-1.84%

Volatility (1Y)

Calculated over the trailing 1-year period

22.42%

24.97%

-2.55%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.46%

28.46%

-2.00%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.28%

29.52%

-3.24%

HEAL vs. IDNA - Expense Ratio Comparison

HEAL has a 0.50% expense ratio, which is higher than IDNA's 0.47% expense ratio.


Dividends

HEAL vs. IDNA - Dividend Comparison

HEAL's dividend yield for the trailing twelve months is around 0.37%, less than IDNA's 0.91% yield.


PositionTTM2025202420232022202120202019
HEAL
Global X HealthTech ETF
0.37%0.33%0.00%0.00%0.00%0.00%0.03%0.00%
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
0.91%1.18%0.98%1.04%0.54%0.70%0.26%0.80%

Frequently Asked Questions


HEAL and IDNA have a correlation of 0.58, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IDNA has higher volatility (7.25%) compared to HEAL (7.15%). In terms of maximum drawdown, HEAL dropped -65.76% vs IDNA's -68.26%.

On 5-year performance, IDNA leads with -8.07% vs -14.74% for HEAL. On fees, IDNA is cheaper at 0.47% per year. On volatility, HEAL has been the lower-risk option at 7.15%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, IDNA has performed better with a -8.07% return vs -14.74%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IDNA is cheaper with a 0.47% expense ratio, compared with 0.50% for HEAL.

IDNA has the higher dividend yield at 0.91%, compared with 0.37% for HEAL.

HEAL tracks Global X HealthTech Index, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. They also come from different issuers: Global X and iShares. Their fees differ too: 0.50% for HEAL and 0.47% for IDNA.

IDNA currently has the higher Sharpe Ratio (2.09 vs -0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HEAL and IDNA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer